One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Molina Healthcare just hit that mark, with a jump from 75 to 89 Friday.
IBD's proprietary RS Rating tracks market leadership by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
Over 100 years of market history shows that the best stocks often have an RS Rating of above 80 as they launch their biggest runs.
Hone Your Stock-Picking Skills By Focusing On These Factors
The IBD 50 stock is trading within a buying range after climbing above a 338.33 entry in a cup with handle. Once a stock moves 5% or higher beyond the initial entry, it's considered out of a proper buying area.
Molina Healthcare reported 15% EPS growth in the latest quarterly report. Sales gains came in at 16%. The next quarterly numbers are expected on or around Apr. 23.
Molina Healthcare holds the No. 1 rank among its peers in the Medical-Managed Care industry group. Cigna Group and UnitedHealth Group are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
